SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Johnson & Johnson
Johnson & Johnson
Page 3 of 18
Finance
The world’s 10 biggest pharmaceutical companies raked in over $700 billion in revenue in 2021
By
Paige McGlauflin
August 15, 2022
Health
Johnson & Johnson to stop selling talc-based baby powder as cancer lawsuits pile on
By
Riley Griffin
,
Jef Feeley
and
Bloomberg
August 11, 2022
Newsletters
The wisdom of J&J’s Alex Gorsky
By
David Meyer
and
Alan Murray
June 10, 2022
Finance
Musk claims S&P ‘lost their integrity’ after Tesla gets booted from sustainability index while Exxon is included
By
Christiaan Hetzner
May 18, 2022
Health
FDA restricts Johnson & Johnson’s COVID-19 vaccine to people 18 and older due to blood clot risk
By
Matthew Perrone
,
Lauran Neergaard
and
The Associated Press
May 5, 2022
Health
The most innovative and inventive drug companies of 2022 set the foundation for success before the pandemic
By
Sy Mukherjee
and
IDEA Pharma
April 20, 2022
Health
The weird case of Novavax’s falling stock price: The vaccine that might be big news for the vax hesitant
By
Andrew Marquardt
March 15, 2022
Leadership
Apple, Walt Disney, and UnitedHealth have this in common: Their business rivals give them ultra-high performance scores
By
Matthew Heimer
and
Scott DeCarlo
February 2, 2022
Health
With Omicron dominant, new COVID cases are up 254%—and those are just the reported ones
By
Erika Fry
and
Nicolas Rapp
January 5, 2022
Health
A Johnson & Johnson booster reduces Omicron hospitalizations by up to 85%, says a new South African study
By
Michelle Fay Cortez
and
Bloomberg
December 30, 2021
Health
Moderna hit by shareholders who want to know why its COVID-19 vaccine is so expensive and unavailable in poorer countries
By
David Meyer
December 27, 2021
Health
J&J, Sputnik, and Sinopharm vaccines found to be largely ineffective in fighting Omicron: study
By
Bloomberg
December 17, 2021
Newsletters
Stocks and crypto falter, looking set to close out the week on a losing streak
By
Bernhard Warner
December 17, 2021
Health
CDC panel recommends Pfizer and Moderna vaccines over Johnson & Johnson
By
Lauran Neergaard
,
Mike Stobbe
and
The Associated Press
December 16, 2021
Health
As COVID deaths top 800,000, Omicron and Delta variants threaten another U.S. surge
By
Erika Fry
and
Nicolas Rapp
December 15, 2021
Most Popular
AI
'Godfather of AI' says the technology will create massive unemployment and send profits soaring — 'that is the...
By
Jason Ma
Success
This Stanford computer science professor went to written exams 2 years ago because of AI. He says his students insisted...
By
Nick Lichtenberg
North America
Farmer says 'we're in a very dire situation' ahead of harvest—with zero soybean orders from China, historically the...
By
Dave Smith